1. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response;Boulet;Am. J. Respir. Crit. Care Med.,1997
2. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis;Casale;J. Allergy Clin. Immunol.,1997
3. Casale, T.B., Condemi, J., LaForce, C., Nyak, A., Rowe, M., Watrous, M., McAlary, M., Fowler-Taylor, A., Gupta, N., Fick, R.B., Rohane, P., Randomized dose-ranging placebo-controlled trial of anti-IgE recombinant humanized monoclonal antibody-E25 (rhuMAb-E25) for the prevention of ragweed pollen-induced seasonal allergic rhinitis. NJEM, in press.
4. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects;Fahy;Am. J. Respir. Crit. Care Med.,1997
5. The binding on human site of interaction between human immunoglobulin E and its high affinity receptor;Presta;J. Biol. Chem.,1994